Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

BIOLASE Inc (BIOL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow BIOLASE's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1768 +0.0317    +21.85%
06/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.1768
0.0000
0.0000%
0:43:45 - Real-time Data
  • Volume: 4,960,258
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.1460 - 0.1899
Type:  Equity
Market:  United States
BIOLASE 0.1768 +0.0317 +21.85%

NASDAQ:BIOL Financials

 
This summary provides an overview of the most significant critical numbers from each of the Biolase financial reports, including theBIOLASE Inc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NASDAQ:BIOL financials over time via breakdowns of their annual reports.

BIOLASE, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 13.49 million compared to USD 14.05 million a year ago. Net loss was USD 5.33 million compared to USD 9.86 million a year ago. Basic loss per share from continuing operations was USD 1.76 compared to USD 128.06 a year ago. Diluted loss per share from continuing operations was USD 1.76 compared to USD 128.06 a year ago.For the full year, sales was USD 49.16 million compared to USD 48.46 million a year ago. Net loss was USD 20.63 million compared to USD 28.63 million a year ago. Basic loss per share from continuing operations was USD 29.44 compared to USD 418.13 a year ago. Diluted loss per share from continuing operations was USD 29.44 compared to USD 418.13 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BIOL Income Statement & Profits

Gross margin TTM 34.02%
Operating margin TTM -34.04%
Net Profit margin TTM -41.97%
Return on Investment TTM -75.28%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 13.49 10.92 14.29 10.47
Gross Profit 3.52 3.75 6.12 3.34
Operating Income -4.68 -3.7 -3.87 -5.29
Net Income -5.33 -4.59 -4.87 -5.85

BIOL Balance Sheet

Quick Ratio MRQ 0.61
Current Ratio MRQ 1.26
LT Debt to Equity MRQ 0%
Total Debt to Equity MRQ -6,359.11%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 35.1 38.74 39.63 41.94
Total Liabilities 33.14 32.86 32.29 33.79
Total Equity 1.96 5.88 7.34 8.16

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -4.13
Revenue/Share TTM 14.39
Operating Cash Flow  -11.60%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -2.28 -2.59 -3.56 -5.66
Cash From Investing Activities -0.003 -0.182 -0.357 -0.587
Cash From Financing Activities 0.885 3.76 4.28 8.52
Net Change in Cash -1.24 0.879 0.398 2.35
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BIOL Price Commentary

Write your thoughts about BIOLASE Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Smooth Operator
Smooth_Operator Mar 01, 2021 12:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good buy, price target 3.5
Ashraf Elgendy
Ashraf Elgendy Feb 26, 2021 14:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
have got. an excellent benifit from. it before.. bought 6000 again in the dip
arigo saki
arigo saki Jan 04, 2021 21:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
strong buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email